| 000 | 01574 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516202421.0 | ||
| 264 | 0 | _c20141118 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1791-3004 | ||
| 024 | 7 |
_a10.3892/mmr.2014.2051 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYin, Honglei | |
| 245 | 0 | 0 |
_aIL-33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF-κB pathways. _h[electronic resource] |
| 260 |
_bMolecular medicine reports _cMay 2014 |
||
| 300 |
_a1834-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Retracted Publication | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aEchocardiography |
| 650 | 0 | 4 |
_aInflammation _xmetabolism |
| 650 | 0 | 4 | _aInterleukin-33 |
| 650 | 0 | 4 |
_aInterleukins _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMyocardial Infarction _xmetabolism |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aVentricular Function, Left |
| 650 | 0 | 4 |
_aVentricular Remodeling _xdrug effects |
| 650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xmetabolism |
| 700 | 1 | _aLi, Peicheng | |
| 700 | 1 | _aHu, Fudong | |
| 700 | 1 | _aWang, Yakun | |
| 700 | 1 | _aChai, Xiaoyan | |
| 700 | 1 | _aZhang, Yan | |
| 773 | 0 |
_tMolecular medicine reports _gvol. 9 _gno. 5 _gp. 1834-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/mmr.2014.2051 _zAvailable from publisher's website |
| 999 |
_c23638014 _d23638014 |
||